Cargando…
The role of post‐translational modifications in cardiac hypertrophy
Pathological cardiac hypertrophy involves excessive protein synthesis, increased cardiac myocyte size and ultimately the development of heart failure. Thus, pathological cardiac hypertrophy is a major risk factor for many cardiovascular diseases and death in humans. Extensive research in the last de...
Autores principales: | Yan, Kaowen, Wang, Kun, Li, Peifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533522/ https://www.ncbi.nlm.nih.gov/pubmed/30950211 http://dx.doi.org/10.1111/jcmm.14330 |
Ejemplares similares
-
The role of K63‐linked polyubiquitination in cardiac hypertrophy
por: Yan, Kaowen, et al.
Publicado: (2018) -
Translating Translation to Mechanisms of Cardiac Hypertrophy
por: Zeitz, Michael J., et al.
Publicado: (2020) -
Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy
por: Dong, Yanhan, et al.
Publicado: (2018) -
Research progress on post-translational modification of proteins and cardiovascular diseases
por: Cheng, XueLi, et al.
Publicado: (2023) -
Post‐translational modifications of the cardiac proteome in diabetes and heart failure
por: Wende, Adam R.
Publicado: (2015)